Drug Profile
Research programme: HIV DNA vaccines - Inovio/IAVI
Alternative Names: HIV DNA vaccines - Inovio/IAVILatest Information Update: 15 Oct 2012
Price :
$50
*
At a glance
- Originator Genetronics Inc
- Developer Genetronics Inc; International AIDS Vaccine Initiative
- Class AIDS vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 15 Oct 2012 No development reported - Preclinical for HIV infections in USA (Intradermal)
- 14 May 2010 Inovio Biomedical is now called Inovio Pharmaceuticals
- 31 Mar 2007 Preclinical trials in HIV infections in USA (IM)